Total Funding
11
Total FundingPost-IPO Debt raised
Growth Score in past quarter
pts
Heat Score 11 in past quarter
-45 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
555972
Relypsa is a biopharmaceutical company developing drugs for treating cardiovascular and renal diseases.
Eric Roul: Associate Director IT Helpdesk & PMOPast Role: Spikes Security, Head of product / IT ops
Mary E Corbett: Senior Vice President of Human Resources
About the Company
Relypsa is a biotech company. They discover and develop non-absorbed polymeric drugs for applications in cardiovascular and renal diseases. They specialize in iron deficiency, nephrology, and cardio-renal therapies.



